Big Gain For Soligenix, Inc.
Soligenix, Inc. (SNGX:NASDAQ) soared at $2.28, a gain of 60.6%. On Thu, May 04, 2023, SNGX:NASDAQ hit a New 2-Week High of $2.28. The stock got featured on our News Catalysts scanner on Thu, May 04, 2023 at 09:43 AM in the 'BIOTECH' category. From Thu, Apr 20, 2023, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Thu, May 04, 2023 at $4.2 with a volume of 36M+.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- Soligenix, Inc. (SNGX:NASDAQ), 60.56%
- Inseego Corp. (INSG:NASDAQ), 52.66%
- SigmaTron International, Inc. (SGMA:NASDAQ), 47.06%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 38.26%
- SRAX, Inc. (SRAX:NASDAQ), 37.5%
- NANO-X IMAGING LTD (NNOX:NASDAQ), 34.96%
- GlucoTrack Inc. (GCTK:NASDAQ), 34.32%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 31.63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 29.81%
- MDJM Ltd. (MDJH:NASDAQ), 28.5%